Results 241 to 250 of about 1,457,300 (387)

Precision medicine in allergic disease—food allergy, drug allergy, and anaphylaxis—PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology

Antonella Muraro, R.F. Lemanske, M. Castells, Marı́a José Torres, David A. Khan, Hans‐Uwe Simon, Carsten Bindslev‐Jensen, Wesley Burks, Lars K. Poulsen, Hugh A. Sampson, Margitta Worm, Kari C. Nadeau   +11 more
openalex   +1 more source

Evaluation of Various Methods of Maternal Placental Blood Collection for Immunology Studies

, 2006
Caroline Othoro, Julie M. Moore, Kathleen Wannemuehler, Bernard L. Nahlen, Juliana A. Otieno, Laurence Slutsker, Altaf A. Lal, Ya Ping Shi   +7 more
openalex   +1 more source

Correction to: SLAMF6 regulates basal T cell receptor signaling and influences invariant natural killer T cell lineage diversity. [PDF]

Int Immunol
europepmc   +1 more source

Widening access to penicillin allergy assessment in the United Kingdom-a proposed implementation plan for the National Health Service (NHS). [PDF]

JAC Antimicrob Resist
Porter CE, Roleston C, Bethune C, Boards J, Brown CS, Clarke I, Fielding J, Howard P, Jamieson C, Misbah SA, Moss AC, Pavitt SH, Powell N, Savic L, Savic S, Krishna MT, Tonkin-Crine S, Williams I, A T Sandoe J.   +18 more
europepmc   +1 more source

Perceptions About Asymptomatic Hyperuricemia and Views About Urate‐Lowering Therapy in People With Asymptomatic Hyperuricemia

Arthritis Care &Research, EarlyView.
Objective Asymptomatic hyperuricemia is a precursor of gout and is also associated with cardiovascular disease and chronic kidney disease. The aim of this study was to understand perceptions about asymptomatic hyperuricemia and views about urate‐lowering therapy in people with asymptomatic hyperuricemia. Methods Participants in a multinational study of
Nicola Dalbeth, Sarah Stewart, Gregory D. Gamble, Borislav Mihov, Lisa K. Stamp, Janine Haslett, William J. Taylor, Tony R. Merriman, Adwoa Dansoa Tabi‐Amponsah, Anne Horne, Tuhina Neogi, Tristan Pascart, Mariano Andrés, Maria‐Luisa Peral‐Garrido, Eleonora Norkuviene, Janitzia Vazquez‐Mellado, Till Uhlig, Mingshu Sun, Changgui Li, Keith J. Petrie   +19 more
wiley   +1 more source

Correction: Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation. [PDF]

Cancer Immunol Immunother
De Maria R, Donini C, Capellero S, Massa A, Galvagno F, Proment A, Vitali L, Vigna E, Landoni E, Dotti G, Leuci V, Accornero P, Conti LC, Olimpo M, Berrino E, Grignani G, Sapino A, Sangiolo D, Aresu L.   +18 more
europepmc   +1 more source

Immunology of psoriasis.

Annual Review of Immunology, 2014
M. Lowes, M. Suárez-Fariñas, J. Krueger   +2 more
semanticscholar   +1 more source

Prevalence, Determinants, and Outcomes of Low Disease Activity and Remission Attainment in Patients With Systemic Lupus Erythematosus That Is Clinically Active

Arthritis Care &Research, EarlyView.
Objective This study aimed to identify in patients with systemic lupus erythematosus (SLE) with clinically active disease the attainment of frequency and determinants of Lupus Low Disease Activity State (LLDAS) and Definition of Remission in SLE (DORIS) and the frequency and determinants of flare and damage accrual after target attainment.
Yanjie Hao, Dylan Hansen, Rangi Kandane‐Rathnayake, Worawit Louthrenoo, Yi‐Hsing Chen, Jiacai Cho, Aisha Lateef, Laniyati Hamijoyo, Shue Fen Luo, Yeong‐Jian Jan Wu, Sandra Navarra, Leonid Zamora, Zhanguo Li, Sargunan Sockalingam, Yasuhiro Katsumata, Masayoshi Harigai, Zhuoli Zhang, Madelynn Chan, Jun Kikuchi, Tsutomu Takeuchi, Sang‐Cheol Bae, Fiona Goldblatt, Sean O'Neill, Kristine (Pek Ling) Ng, Annie Law, B. M. D. B. Basnayake, Nicola Tugnet, Sunil Kumar, Cherica Tee, Michael Tee, Naoaki Ohkubo, Yoshiya Tanaka, Shirley Chan, C. S. Lau, Vera Golder, Alberta Hoi, Shereen Oon, Eric Morand, Mandana Nikpour, for the Asia‐Pacific Lupus Collaboration   +39 more
wiley   +1 more source

Author Correction: Not marginal but central: type I interferons unleash marginal zone B cells in Sjögren's disease. [PDF]

Cell Mol Immunol
Werynski A, Li CX, Hao Y, Cerutti A, Chen K.   +4 more
europepmc   +1 more source

Preferences for post‐traumatic osteoarthritis prevention strategies in individuals with anterior cruciate ligament injury

Arthritis Care &Research, Accepted Article.
Objectives There is growing interest in evaluating new strategies to delay or prevent post‐traumatic osteoarthritis (PTOA) in individuals who have sustained anterior cruciate ligament (ACL) injury. This study sought to determine characteristics of potential treatments that are acceptable to patients with ACL injury.
Kevin Kennedy, Lily Waddell, Adam Easterbrook, Jeffrey N. Katz, Cale Jacobs, Morgan Jones, Faith Selzer, Elena Losina, Liana Fraenkel, Nick Bansback   +9 more
wiley   +1 more source